Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.
Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER. Riekse RG, et al. Among authors: seubert p. J Alzheimers Dis. 2006 Dec;10(4):399-406. doi: 10.3233/jad-2006-10408. J Alzheimers Dis. 2006. PMID: 17183151 Clinical Trial.
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
Bekris LM, Galloway NM, Millard S, Lockhart D, Li G, Galasko DR, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Leverenz JB, Seubert P, Tsuang DW, Peskind ER, Yu CE. Bekris LM, et al. Among authors: seubert p. Neurobiol Aging. 2011 Mar;32(3):556.e13-23. doi: 10.1016/j.neurobiolaging.2010.10.020. Epub 2010 Dec 31. Neurobiol Aging. 2011. PMID: 21196064 Free PMC article.
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Among authors: seubert p. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.
Mice as models: transgenic approaches and Alzheimer's disease.
Games D, Buttini M, Kobayashi D, Schenk D, Seubert P. Games D, et al. Among authors: seubert p. J Alzheimers Dis. 2006;9(3 Suppl):133-49. doi: 10.3233/jad-2006-9s316. J Alzheimers Dis. 2006. PMID: 16914852 Review.
Longitudinal stability of CSF tau levels in Alzheimer patients.
Sunderland T, Wolozin B, Galasko D, Levy J, Dukoff R, Bahro M, Lasser R, Motter R, Lehtimäki T, Seubert P. Sunderland T, et al. Among authors: seubert p. Biol Psychiatry. 1999 Sep 15;46(6):750-5. doi: 10.1016/s0006-3223(99)00143-2. Biol Psychiatry. 1999. PMID: 10494442
98 results